Safety of Elranatamab in Patients with Triple-Class Refractory Relapsed/Refractory Multiple Myeloma (RRMM) in Magnetismm-17, a North American Expanded Access ProtocolNizar J. Bahlis,Suzanne Trudel,Christopher Maisel,Lisa X. Lee,Jorge Monge,Claudia Paba Prada,Sarah M. Larson,Guenther Koehne,Yogesh Jethava,Wei Dong Ma, Cristina De Nicolo, Isabel Perez-CruzBLOOD(2023)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要